Metal chelation in tetramates may
be ameliorated by changing the
ligating group and by steric blocking, which in turn leads to a change
in their antibacterial properties; the former was achieved by replacement
of an amide with a C-9 CN bond and the latter by the synthesis
of cysteine-derived tetramates with functionalization at the C-6 or
C-9 enolic groups. In both cases, the metal-chelating ability was
weak, and a loss of antibacterial activity was observed. Tetramate
alkylations with an extended tricarbonyl-conjugated system could be
achieved under Mitsunobu conditions which led to regioisomers, distinguishable
by careful heteronuclear multiple bond coherence correlation and carbonyl
carbon chemical shift analysis. C-9 and C-6 O-alkylation were observed
but not C-8 O-alkylation for tetramate carboxamides; interestingly,
C-7 alkylation with allyl and prenyl derivatives was also observed,
and this arose by the rearrangement of initially formed O-alkyl products. Only the C-7 alkylated tetramate derivatives 13a and 13d with no metal-chelating ability demonstrated
promising antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), with the most active
analogue exhibiting a minimum inhibitory concentration of ≤
1.95 μg/mL against MRSA, suggesting a mechanism of action independent
of metal chelation. Otherwise, modifications at C-6/C-9 of tetramates
led to a complete loss of metal-chelating ability, which correlated
with the loss of antibacterial activity. This work further confirms
that the metal-chelating capability is of fundamental importance in
the biological activity of tetramates.